Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer
Clinical trial NCT02347332 · COMPLETED
Trial details
- NCT number
- NCT02347332
- Sponsor
- Pierre Fabre Medicament
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-25
- Primary completion
- 2017-10-20
- Enrollment
- 459
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.